Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Current Taxes (2019 - 2026)

Phibro Animal Health has reported Current Taxes over the past 7 years, most recently at $10.7 million for Q4 2025.

  • For Q4 2025, Current Taxes rose 178.52% year-over-year to $10.7 million; the TTM value through Dec 2025 reached $10.7 million, up 178.52%, while the annual FY2025 figure was $8.4 million, 186.49% up from the prior year.
  • Current Taxes for Q4 2025 was $10.7 million at Phibro Animal Health, up from $10.6 million in the prior quarter.
  • Over five years, Current Taxes peaked at $10.7 million in Q4 2025 and troughed at $2.9 million in Q2 2024.
  • A 5-year average of $6.6 million and a median of $6.4 million in 2021 define the central range for Current Taxes.
  • Biggest five-year swings in Current Taxes: plummeted 66.17% in 2024 and later surged 186.49% in 2025.
  • Year by year, Current Taxes stood at $6.5 million in 2021, then grew by 10.03% to $7.2 million in 2022, then dropped by 19.81% to $5.8 million in 2023, then plummeted by 33.52% to $3.8 million in 2024, then skyrocketed by 178.52% to $10.7 million in 2025.
  • Business Quant data shows Current Taxes for PAHC at $10.7 million in Q4 2025, $10.6 million in Q3 2025, and $8.4 million in Q2 2025.